Synektik (FRA:A2P) FFO


FRA:A2P Synektik SA FRA:A2P
60 GF Score
Price €83.70
GF Value €52.48
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Synektik FFO?

FFO (Funds from operations) only applies to REITs.

FRA:A2P
60GF Score
Synektik SA FRA:A2P
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Synektik (FRA:A2P) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of €83.70 is trading 59.5% above its estimated GF Value™ of €52.48. GuruFocus considers Synektik to be Significantly Overvalued.

Key valuation signals for FRA:A2P:

  • FFO:
  • GF Value™: €52.48 vs. price of €83.70 (59.5% above fair value)
  • GF Score™: 60/100 with 7 warning signs

No single metric tells the full story. See the FRA:A2P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synektik Business Description

Other Exchanges SNT:Poland
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
60GF Score

Get the complete analysis for FRA:A2P

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€83.70
Price
€52.48
GF Value